Protagonist Therapeutics Inc buy JPMorgan Chase & Co.
Start price
07.11.25
/
50%
€69.00
Target price
07.11.26
€70.20
Performance (%)
0.00%
Price
09.01.26
€69.00
Summary
This prediction is currently active. JPMorgan_Chase___Co_'s BUY prediction for Protagonist Therapeutics Inc is currently unchanged. This prediction currently runs until 07.11.26. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -8.609% | -8.609% |
| iShares Core DAX® | 3.002% | 4.755% |
| iShares Nasdaq 100 | 2.966% | 0.363% |
| iShares Nikkei 225® | 5.606% | 4.528% |
| iShares S&P 500 | 2.312% | 1.811% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics (NASDAQ:PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $68.00 to $81.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.03.25
04.03.25
€54.07
04.03.26
04.03.26
36.63%
09.01.26
09.01.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
04.02.25
04.02.25
€51.09
04.02.26
04.02.26
36.63%
09.01.26
09.01.26
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€50.50
25.07.24
25.07.24
€44.18
25.07.25
25.07.25
-4.16%
26.07.25
26.07.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
28.02.24
28.02.24
€34.13
28.02.25
28.02.25
-
01.03.25
01.03.25
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€69.00
25.09.23
25.09.23
€32.11
25.09.24
25.09.24
-
26.09.24
26.09.24